Skip to content

Clinical trials

Phase 2 Schizophrenia trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2 Country / region: Spain Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20141
20162
20171
20182
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Neurocrine Biosciences2
ACADIA Pharmaceuticals Inc.1
Amgen1
Clinica Universidad de Navarra, Universidad de Navarra1
Denovo Biopharma LLC1
H. Lundbeck A/S1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Jazz Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia12
Cognitive Dysfunction1
Psychotic Disorders1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.